PREVENT HPV-Related Cancers - BootCamp Translation

Summary

This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, this intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States.

The proposed study will determine the components of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington. This study is a boot camp translation to tailor messaging based on patient and provider input.

This study will refine intervention components and messages to increase HPV vaccination among rural children and adolescents (C/A). The research team will use a validated patient-engaged approach for parents/caregivers (P/Cs), Bootcamp Translation (BCT), with separate sessions conducted in English and Spanish.

Conditions

• HPV Vaccination
• Vaccine; Uptake
• Vaccination; Series Completion

Interventions

BEHAVIORAL

PREVENT - BCT

Bootcamp Translation (BCT), a method for engaging diverse stakeholders in a consensus-building process, has been used by this research team to actively develop and adapt study interventions. It uses an iterative, flexible schedule of face-to-face meetings combined with short, focused teleconferences. BCT emphasizes no wrong answers and no hierarchy of expertise. The process requires up to nine (9) hours of participant time over 3-6 months. Participants will be surveyed before and after the in-person session to assess learning outcomes and capture basic sociodemographic information. The BCT process will define the format (mode and frequency) and content of messages to promote vaccine series completion. Auto and Auto-Plus intervention arms may use some of the same components (automated calls, live calls, text messages, emails, and mailings).

Sponsors & Collaborators

• Kaiser Permanente

  collaborator OTHER

• University of Arizona

  collaborator OTHER

• Sea Mar Community Health Centers

  collaborator OTHER

• National Cancer Institute (NCI)

  collaborator NIH

• University of Utah

  lead OTHER

Principal Investigators

• Deanna Kepka, PhD, MPH · Huntsman Cancer Institute/ University of Utah

• Medical Director, MD · Sea Mar

Study Design

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2024-02-02

Primary Completion

2024-03-01

Completion

2024-03-31

Countries

• United States

Study Locations